TAPPING THE POTENTIAL OF HUNGARY: EMERGING MARKETS CASE STUDY A mid-sized pharmaceutical company engaged Covance to help conduct a Phase IIb global clinical trial for their chronic obstructive pulmonary disease (COPD) inhalant. The study involved nearly 600 patients in approximately 120 sites. Understanding the Challenge ? Site and investigator familiarity with COPD and its treatment options ? Obtaining consistent quality data from the spir

Join for free to read